Nizapex Shampoo

Quick links

Choose a section

Quick links to important sections

Advertisements

Nizapex Shampoo

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Nizapex Shampoo

Property Description
Active Ingredient Ketoconazole (INN)
Form Topical Liquid Preparation (Medicated Shampoo)
Pharmacological Class Antifungal Agent (Imidazole Derivative)
General Purpose Controlling fungal and yeast overgrowth on skin and scalp
Origin Synthetic Compound

What Type of Medicine is Nizapex Shampoo?

Nizapex Shampoo is defined as a synthetic Antifungal Agent, categorized as a topical liquid preparation intended for cutaneous application. This product belongs to the Imidazole derivative pharmacological class, a family of compounds clinically recognized for their ability to inhibit the growth of various fungi and yeasts. The choice of a medicated shampoo as the dosage form is a key differentiating factor, making it suitable for targeted application across the scalp and larger skin areas.

As a single-active-ingredient product, its formulation is centered entirely on the properties of its active substance, distinguishing it from conventional hair care or non-medicated topical solutions.


Active Ingredient and Form: The Role of Ketoconazole

The core pharmaceutical component is Ketoconazole (INN), which is formulated within an aqueous surfactant solution base. Ketoconazole exerts its effect by disrupting the structure of the fungal cell membrane, primarily through the inhibition of ergosterol synthesis.

This specific composition utilizes a liquid vehicle to ensure optimal contact and uniform distribution of the potent antimycotic agent across the affected external tissues. The product's identity as a topical formulation underscores its function as a localized treatment.


General Therapeutic Purpose

The primary therapeutic purpose of this preparation is to stabilize the skin and scalp environment by controlling the proliferation of fungal pathogens, particularly susceptible yeasts. This general utility relates to the efficacy of Ketoconazole in this context. By interfering with the fungi's growth mechanism, the shampoo helps restore the microbial balance on the external skin surface, addressing the discomfort that stems directly from the pathogenic activity.

Regulatory References

  1. Ketoconazole - StatPearls - NCBI Bookshelf
Advertisements

What side effects are possible with Nizapex Shampoo?

Possible Side Effects and Safety Information

Nizapex Shampoo's safety profile is characterized by effects primarily localized to the application area, consistent with its topical formulation. Adverse reactions are classified by frequency tiers established in official regulatory documentation from agencies like the EMA and FDA.


Officially Documented Adverse Reactions

Frequency Category Description of Effects (Selected Examples)
Uncommon (ge 1/1,000 to <1/100) Folliculitis, Alopecia (hair loss), Dry skin, Rash, Skin burning sensation, Application site irritation, and Application site pruritus (itching).
Rare (ge 1/10,000 to <1/1,000) Hypersensitivity, Dysgeusia (taste disturbance), Increased lacrimation, Eye irritation, and Dermatitis contact.
Not Known Angioedema, Urticaria (hives), and Hair colour changes.

Adverse effects are grouped into System-Organ Classes including Skin and Subcutaneous Tissue Disorders, General Disorders and Administration Site Conditions, and Immune System Disorders.


Serious Reactions and Safety Constraints

Post-marketing reports document severe hypersensitivity reactions, including anaphylaxis and angioedema, though the frequency is classified as Not Known. The product is contraindicated for individuals with a known hypersensitivity to its active ingredient, Ketoconazole, or any of its excipients.

Population-Specific Safety Notes

Systemic exposure is minimal; plasma concentrations of Ketoconazole are typically not detectable after chronic scalp application. Regarding special populations, safety and effectiveness have not been established in children. When transitioning from prolonged topical corticosteroid use, regulatory documents note a potential for a rebound effect if the steroid is not gradually withdrawn.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Nizapex Shampoo emphasizes that overdose is not expected from the product’s proper topical application due to minimal systemic absorption. The official guidance is strictly focused on the necessary emergency actions following accidental oral ingestion of the liquid preparation.

Required Emergency Actions

If the shampoo is swallowed, urgent medical attention must be sought immediately. The primary risk addressed by regulatory authorities is the potential for pulmonary aspiration of the liquid vehicle, which is an acute hazard following ingestion.

Action Mandate (Official Labeling) Description
Immediate Help Seek urgent medical attention or contact a poison control center right away.
Management Type Management must be symptomatic and supportive.
Prohibited Procedures Do NOT induce emesis (vomiting) and do NOT perform gastric lavage due to the severe risk of aspiration.

Official documents state that no specific antidote for ketoconazole is known. The management protocol focuses entirely on supportive care and the critical avoidance of procedures that could increase the risk of aspiration.

Advertisements

Therapeutic Uses of Nizapex Shampoo

The product is commonly used in situations involving certain distressing symptoms in dermatological contexts and may assist with symptomatic relief in associated dermatological conditions.

Management of Chronic Scalp Flaking and Itching

Nizapex Shampoo is commonly used across conditions presenting with recurrent or episodic manifestations, primarily Seborrhoeic Dermatitis and Pityriasis Capitis (dandruff). It is commonly used to help with symptom clusters that may involve itching (pruritus), flaking, and scaling, which contributes to easing the overall symptom load during symptomatic periods.

Treatment of Pityriasis Versicolor and Skin Discoloration

The product is also relevant for easing symptoms that may arise from the localized irritative states of Pityriasis Versicolor (Tinea Versicolor) on the body. It is applied to help manage symptoms associated with the infection that may include discolored patches, which supports general well-being during symptomatic phases.

Control of Persistent and Recurrent Symptoms

For patients who experience recurrent or stubborn symptoms, this preparation may be part of symptomatic management. It is applied in situations where patients experience recurrent or episodic manifestations. This provides support that helps ease the overall symptom burden over time.


Quick Fact: Relevant for Symptoms of Recurrent Flaking and Itching
This preparation is applied in clinical settings that involve recurrent or unstable symptom patterns, and supports patients during episodes by easing symptomatic discomfort.
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Nizapex Shampoo — Official Regulatory Information

Eligibility Scope

Populations for whom use is allowed: Use is established for Adults and Adolescents (generally 12 years of age and older).

Populations for whom use is contraindicated: Persons with known hypersensitivity to the active ingredient Ketoconazole or to any excipients in the formulation (Absolute Prohibition).

Age-related eligibility rules: Safety and effectiveness have not been established in the pediatric population, specifically children under 12 years of age. Use in this group is officially not recommended.

Pregnancy and lactation eligibility status:

  • Pregnancy: Conditional use, classified as FDA Category C. It should be used only if the potential benefit justifies the risk, citing a lack of adequate human studies.
  • Lactation: Conditional use, as caution should be exercised when administered to a nursing woman.

Eligibility-related restrictions: Patients must implement a gradual withdrawal of prolonged topical corticosteroid therapy over 2–3 weeks while initiating the shampoo. Use should also be avoided on broken or inflamed skin.


Resulting Eligibility Structure

Official eligibility statements:

  • Contraindicated due to ingredient hypersensitivity.
  • Safety and effectiveness not established in children.
  • Use requires a gradual withdrawal of existing topical corticosteroid treatment.

Connection to the overall eligibility profile (2–4 sentences): The regulatory profile defines eligibility through explicit constraints: an absolute prohibition for individuals with ingredient sensitivity and a not established status for the pediatric population. Use during pregnancy and lactation is conditional, requiring caution based on the absence of adequate studies. These official classifications authorize or restrict the medicine’s use for specific population groups.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Nizapex Shampoo (ketoconazole 2% topical preparation) is determined by its route of administration, which results in negligible systemic absorption of the active ingredient. Regulatory prescribing information confirms that plasma concentrations of ketoconazole are generally not detectable after the recommended use on the scalp.

Pharmacokinetic Interaction Risk

Due to this low systemic exposure, the product is not associated with the drug-drug interactions, such as those involving CYP enzymes, which are documented for oral ketoconazole. Official regulatory documents indicate that no systemic drug interactions are anticipated with co-administered medicines, and clinical interaction studies have not been performed for the shampoo formulation.

Administrative Precaution: Topical Corticosteroids

The only official constraint is an administrative timing requirement for patients who have been using potent topical corticosteroids on the scalp. To prevent a potential pharmacological rebound effect upon cessation, the regulatory label requires a controlled, gradual withdrawal of the steroid treatment over a period of two to three weeks while the shampoo is being introduced. No documented interactions exist with food, alcohol, or herbal products for this topical formulation.

Advertisements

Mechanism of Action

The action of the active ingredient, Ketoconazole, is confined to the fungal organism and is defined by its targeted capacity to compromise the integrity of the fungal cell membrane. The overall mechanism is driven by highly localized enzyme inhibition.

Inhibiting Fungal Structural Synthesis

Ketoconazole functions by directly binding to and inhibiting the critical fungal enzyme, Cytochrome P450 14 alpha-demethylase (CYP51A1). This mechanism arrests the necessary metabolic step that converts lanosterol into ergosterol, the fundamental structural lipid required to construct the fungal cell membrane. The result is the functional arrest of the fungal organism's ability to maintain its basic physical architecture.

Compromising Pathogen Cell Integrity

The inhibition of the CYP51A1 enzyme creates a dual effect: it depletes the supply of essential ergosterol and simultaneously causes an accumulation of abnormal, toxic sterols within the cell. This severely compromises the fungal cell membrane, increasing its permeability and causing the leakage of vital internal components. This physiological defect rapidly leads to the arrest of cell replication (fungistatic effect) and, at high local concentrations, the direct collapse and loss of cell viability (fungicidal effect).

Advertisements

Dosage and Administration Information

Administration Guidelines

Nizapex Shampoo, a topical liquid preparation containing 2% Ketoconazole, is indicated for cutaneous application only. The regimen for use is organized around distinct frequencies for initial treatment and long-term control.

Administration Scope & Classification Standard Application Principle
Administration Method Type Topical (Cutaneous) only; strictly for external use.
Seborrhoeic Dermatitis Regimen Initial treatment involves application twice weekly for two to four weeks, followed by intermittent use (e.g., once every one to two weeks) for maintenance.
Pityriasis Versicolor Regimen The treatment course involves either a single application or a daily application for a total course duration of up to three to five consecutive days.
Contact Time Requirement The product must be applied to the damp affected area and lathered, remaining in place for three to five minutes before thorough rinsing.
Age-Group Rule Safety and effectiveness have not been established in children for the 2% formulation.

Resulting Procedural Structure

Procedural step sequence:

  • Application of the product to the damp affected area and surrounding margin.
  • Maintenance of product contact for the specified duration of 3 to 5 minutes.
  • Thorough rinsing of the area with water following the contact period.

Connection to the Overall Use Protocol

The instructions define a standardized topical protocol determined by the condition being managed. The protocol necessitates adherence to a specific contact time and a variable frequency pattern, which may involve a short, daily course for acute conditions or a long-term, intermittent model for managing recurrence. This process includes a procedural constraint that requires gradual withdrawal of any prior topical corticosteroid therapy over two to three weeks when commencing the shampoo.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Nizapex Shampoo

Evidence for Use in Seborrhoeic Dermatitis and Dandruff

Research for Nizapex Shampoo (Ketoconazole) includes numerous short-term, randomized controlled trials (RCTs). These trials are study designs that include masking (blinding) to maximize objectivity by ensuring neither the participants nor the researchers knew whether the medicated shampoo or a non-medicated placebo was used, alongside trials involving other active preparations. Research examined populations of adults and adolescents who were experiencing fluctuating or unstable symptoms of the scalp, such as periods of heightened scaling and itching.

Researchers examined changes in physical discomfort by using clinical scales to measure the intensity of scaling, flaking, and pruritus (itching). Studies also conducted laboratory testing for the presence or absence of the Malassezia yeast. Findings describe the differences in patterns observed between the groups using the medicated shampoo and the non-medicated control. Research highlights changes measured during the study period, contributing to the broader evidence landscape.


Evidence for Use in Pityriasis Versicolor

Research related to Pityriasis Versicolor, a condition characterized by fluctuating or episodic manifestations like skin discoloration, involved different research scenarios. Studies explored short-contact treatment protocols, sometimes involving just a single application or a few days of use, often compared to a placebo or other topical preparations.

The main assessments involved monitoring physiological strain or stress, specifically assessing the mycological status of the skin—checking in a lab if the fungus was still present. Findings reported patterns where mycological clearance (absence of the fungus in lab tests) was observed in the studied populations at the initial follow-up. Research also examined the visual appearance of the affected skin, focusing on outcomes linked to inflammatory or irritative states such as scaling and the extent of lesions.


Key Research Gaps and Uncertainties

Research has explored many aspects of Nizapex Shampoo, but evidence highlights what is known—and what is still uncertain. Follow-up durations were limited in the primary efficacy studies, meaning findings are most applicable to research on acute or episodic symptoms. Data are still emerging for the best studied approaches related to long-term use and recurrence management. Specifically, there is limited information for long-term outcomes and the lack of comprehensive data for children under 12 continues to be a noted research limitation in regulatory documents.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nizapex Shampoo (FAQ)

Q: How is Nizapex Shampoo different from regular cosmetic shampoos?

A: Nizapex Shampoo is classified as a synthetic antifungal agent intended for cutaneous application to address fungal overgrowth on the skin and scalp. Unlike cosmetic shampoos, the official instructions indicate the product must remain on the affected area for a specific contact time of three to five minutes before rinsing for the active ingredient to be effective.


Q: How quickly do users typically notice an effect from Nizapex Shampoo?

A: According to official product information, improvement in symptoms is generally expected to be observed during the initial treatment period, which typically lasts two to four weeks for seborrhoeic dermatitis. If symptoms do not start to improve during this initial time frame, regulatory guidance notes that consulting a healthcare provider is recommended.


Q: If a use is missed, what is the general recommendation?

A: If an application is missed, it can be applied as soon soon as it is remembered. However, if it is nearly time for the next scheduled application, the official recommendation is to skip the missed one and continue with the regular schedule. The product label advises against using a double quantity to try and make up for the missed application.


Q: Is it common to notice changes in hair texture when first starting Nizapex Shampoo?

A: Official safety data reports that abnormal hair texture is a possible adverse reaction. Other officially documented effects include hair discoloration and the removal of the curl from permanently waved hair. Official safety data indicates these effects are reported as uncommon or of unknown frequency.


Q: Are there known interactions between Nizapex Shampoo and commonly used hair styling products?

A: Due to the negligible systemic absorption of the active ingredient, no systemic drug interactions are anticipated with co-administered medicines. The only official administrative constraint is related to patients using potent topical corticosteroids, which requires a controlled, gradual withdrawal of the steroid treatment over two to three weeks when starting the shampoo.


Q: Can Nizapex Shampoo be used on hair that has been color-treated or permed?

A: The official prescribing information reports that use of the shampoo has resulted in the removal of the curl from permanently waved hair. Additionally, hair color changes have been reported as an adverse reaction of unknown frequency.


Q: Are there any ingredients in Nizapex Shampoo that commonly cause allergic reactions?

A: The product is contraindicated (not allowed) for people with a known hypersensitivity to the active ingredient, Ketoconazole, or any of the inactive ingredients (excipients). Regulatory documents specifically note that the excipient Benzyl Alcohol may cause local irritation or allergic reactions in sensitive individuals.


Q: Do studies indicate Nizapex Shampoo maintains its effectiveness over a long period of time?

A: The primary efficacy studies focused on acute or episodic symptoms and had limited follow-up durations. Regulatory documents note that comprehensive information for long-term outcomes and recurrence management is still emerging and remains a limitation in the current research base.


Q: Is the scalp supposed to tingle or feel warm after using Nizapex Shampoo?

A: Skin burning sensation is listed in official documents as an uncommon or post-marketing adverse reaction. The sensation is not described as a normal part of the medicine's mechanism of action. If a reaction suggesting sensitivity or chemical irritation occurs, this is important safety information to be aware of.


Q: Does Nizapex Shampoo contain common ingredients like sulfates or parabens?

A: According to the official excipient list for the 2% formulation, a type of sulfate—Sodium Lauryl Ether Sulfate or Sodium Laureth Sulfate—is included in the preparation.


Q: What is the difference between a prescription-strength Nizapex Shampoo and an over-the-counter version?

A: The core difference is the concentration of the active ingredient, Ketoconazole. The 2% strength is generally available by prescription, while a 1% strength is often sold over-the-counter (OTC). Clinical studies indicate the 2% strength has been associated with superior results in clinical assessment for reducing flakiness and the density of Malassezia yeast.


Q: What are the possible signs that Nizapex Shampoo might not be working for a user's condition?

A: Regulatory guidance directs patients to consult their healthcare provider if their symptoms do not start to improve during the initial prescribed treatment course (typically two to four weeks). Consulting a provider is also advised if symptoms get worse at any point during use.


Q: Can Nizapex Shampoo be used on body areas other than the scalp?

A: The product is a topical preparation intended for cutaneous application (application to the skin) and is not restricted solely to the scalp. Official guidelines specify its use for conditions like Pityriasis Versicolor, which affects skin areas on the body.


Q: Are there restrictions on using other topical creams or ointments on the scalp at the same time?

A: There are no documented systemic interactions with other topical products due to the shampoo's negligible absorption into the body. However, for patients using potent topical corticosteroids on the affected area, the label requires a controlled, gradual withdrawal of the steroid treatment over two to three weeks while starting the shampoo.


Q: Does exposure to sunlight affect the chemical stability or effectiveness of Nizapex Shampoo?

A: The product must be protected from light and stored at the specified room temperature to maintain its pharmaceutical integrity. For the treatment of Pityriasis Versicolor, the official regimen may involve using the shampoo prophylactically before expected sunshine exposure, as the condition can become more noticeable in the sun.


Q: Is Nizapex Shampoo considered generally safe for people with certain chronic skin conditions?

A: Official eligibility criteria indicate that use of the product is generally not recommended on areas of broken or inflamed skin. Regulatory documents also advise discontinuing use if a reaction suggesting sensitivity or chemical irritation occurs.


Q: Why might a doctor prescribe Nizapex Shampoo instead of recommending a similar OTC product?

A: The core difference is the concentration of the active ingredient, Ketoconazole. The 2% strength requires a prescription, while a 1% strength is often available over-the-counter. Clinical studies indicate the 2% strength has been associated with superior results in clinical assessment for reducing flakiness and the density of Malassezia yeast compared to the 1% strength.


Q: How does Nizapex Shampoo affect the natural oil balance (sebum) on the scalp?

A: Official safety information reports that possible adverse effects include both dry skin and changes to the hair and scalp, such as oiliness or dryness. The product's main function is the localized disruption of fungal cell membranes.


Q: Can Nizapex Shampoo be used on facial hair or beards?

A: The product is a topical liquid preparation intended for cutaneous application on affected areas of the skin. Since Seborrhoeic Dermatitis, one of the conditions the shampoo is used for, commonly affects the face and beard area, the use on these areas may be part of the therapeutic application.


Q: Do specific populations show different rates of response to Nizapex Shampoo in clinical trials?

A: The primary efficacy studies focused on populations of adults and adolescents (generally 12 years of age and older). Official documents note that safety and effectiveness have not been established in the pediatric population, specifically children under 12 years of age.

Advertisements

How should Nizapex Shampoo be stored and disposed of?

How to Store and Dispose of Nizapex Shampoo

Nizapex (ketoconazole) shampoo must be stored under specific conditions to maintain its pharmaceutical integrity and ensure household safety, as mandated by regulatory labeling.


Official Storage Requirements

Condition Regulatory Mandate
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F), protecting from temperatures outside the permitted excursion range.
Handling/Stability The product must be protected from freezing and protected from light. Keep the bottle tightly closed when not in use.
Child Safety Mandatory to store the shampoo out of the reach of children.

Disposal Instructions

Unused or expired Nizapex shampoo must be disposed of according to local environmental requirements. The disposal of empty or partially empty containers through the community's solid waste system is not anticipated to cause adverse environmental effects, as stated in regulatory assessments.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Nizapex Shampoo found in:

A-Z Index: